Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

5.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The PRECISE European initiative for cancer-vulnerability mapping and prediction.

Nature genetics·2026
Same author

An AI-Powered Trisomy 21 Research Assistant.

bioRxiv : the preprint server for biology·2026
Same author

Reduced PRC2 function causes asparaginase resistance in T-ALL by decreasing WNT pathway activity.

Blood advances·2026
Same author

nf-core/crisprseq: a versatile pipeline for comprehensive analysis of CRISPR gene editing and screening assays.

NAR genomics and bioinformatics·2026
Same author

Reduced PRC2 function causes asparaginase resistance in T-ALL by decreasing WNT pathway activity.

Blood advances·2025
Same author

A compendium of synthetic lethal gene pairs defined by extensive combinatorial pan-cancer CRISPR screening.

Genome biology·2025

Related Experiment Video

Updated: Jan 16, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

Benchmarking genetic interaction scoring methods for identifying synthetic lethality from combinatorial CRISPR

Hamda Ajmal1,2,3, Sutanu Nandi1,2,3,4, Narod Kebabci1,2,5

  • 1Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, D04 V1W8, Ireland.

NAR Genomics and Bioinformatics
|September 29, 2025
PubMed
Summary

Synthetic lethality (SL) involves disrupting two genes to kill cancer cells. This study compares five methods for identifying SL interactions from CRISPR screens, finding two top performers, including Gemini-Sensitive.

More Related Videos

Pooled CRISPR-Based Genetic Screens in Mammalian Cells
09:05

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

23.1K
Genetic Screen for Identification of Multicopy Suppressors in Schizosaccharomyces pombe
13:22

Genetic Screen for Identification of Multicopy Suppressors in Schizosaccharomyces pombe

Published on: September 13, 2022

2.2K

Related Experiment Videos

Last Updated: Jan 16, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K
Pooled CRISPR-Based Genetic Screens in Mammalian Cells
09:05

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

23.1K
Genetic Screen for Identification of Multicopy Suppressors in Schizosaccharomyces pombe
13:22

Genetic Screen for Identification of Multicopy Suppressors in Schizosaccharomyces pombe

Published on: September 13, 2022

2.2K

Area of Science:

  • Genetics
  • Genomics
  • Cancer Biology

Background:

  • Synthetic lethality (SL) is a genetic interaction where disabling two non-essential genes causes cell death.
  • SL strategies offer targeted cancer therapies by exploiting tumor-specific mutations, potentially reducing side effects.
  • Pooled combinatorial CRISPR screens are crucial for identifying SL targets in cancer research.

Purpose of the Study:

  • To systematically compare the performance of five different scoring methods for detecting synthetic lethality from CRISPR screens.
  • To evaluate these methods across multiple CRISPR datasets and identify robust approaches for SL target discovery.

Main Methods:

  • Conducted a comprehensive analysis of five scoring algorithms for synthetic lethality detection.
  • Utilized five independent combinatorial CRISPR screen datasets for evaluation.
  • Assessed algorithm performance using two distinct benchmarks of paralog synthetic lethality.

Main Results:

  • No single scoring method consistently outperformed others across all tested CRISPR screen datasets.
  • Identified two scoring methods that demonstrated strong performance across the majority of datasets.
  • The Gemini-Sensitive score, with an available R package, was highlighted as a practical choice for various screen designs.

Conclusions:

  • The choice of scoring method significantly impacts synthetic lethality detection in CRISPR screens.
  • Gemini-Sensitive and another method show promise for reliable SL target identification across diverse datasets.
  • The availability of user-friendly tools like the Gemini-Sensitive R package facilitates the application of these methods in cancer research.